aluates Reports

$ 0.0

Automative

Global Healthcare Nanomedicine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-4Q18624

Healthcare Nanomedicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BUY CHAPTERS

Global Healthcare Nanomedicine Market Research Report 2025

Code: QYRE-Auto-4Q18624

Report

May 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Teva Pharmaceuticals

UCB

Roche

Celgene

Sanofi

Merck

Biogen

Gilead Sciences

Pfizer Inc

Leadiant Biosciences

Kyowa Hakko Kirin

Takeda

Ipsen S A

Endo International

Healthcare Nanomedicine Market Size

The global market for Healthcare Nanomedicine was valued at US$ 241380 million in the year 2024 and is projected to reach a revised size of US$ 466110 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Healthcare Nanomedicine Market

Healthcare nanomedicine refers to the application of nanotechnology in the field of medicine and healthcare. Nanotechnology involves manipulating materials at the nanoscale, typically at the level of atoms and molecules, to create structures and devices with unique properties and capabilities. When applied to healthcare, nanomedicine offers promising solutions for disease diagnosis, treatment, and prevention.

North American market for Healthcare Nanomedicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Healthcare Nanomedicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Healthcare Nanomedicine in Anticancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Healthcare Nanomedicine include Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Gilead Sciences, Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Healthcare Nanomedicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Nanomedicine.

The Healthcare Nanomedicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Healthcare Nanomedicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Healthcare Nanomedicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Healthcare Nanomedicine Market Report

Report Metric	Details
Report Name	Healthcare Nanomedicine Market
Accounted market size in year	US$ 241380 million
Forecasted market size in 2031	US$ 466110 million
CAGR	10.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nanoparticle Drug Nanocarrier Drug
Segment by Application	Anticancer CNS Product Anti-infective Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Gilead Sciences, Pfizer, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare Nanomedicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Healthcare Nanomedicine Market growing?

Ans: The Healthcare Nanomedicine Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Healthcare Nanomedicine Market size in 2031?

Ans: The Healthcare Nanomedicine Market size in 2031 will be US$ 466110 million.

Who are the main players in the Healthcare Nanomedicine Market report?

Ans: The main players in the Healthcare Nanomedicine Market are Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Gilead Sciences, Pfizer, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International

What are the Application segmentation covered in the Healthcare Nanomedicine Market report?

Ans: The Applications covered in the Healthcare Nanomedicine Market report are Anticancer, CNS Product, Anti-infective, Other

What are the Type segmentation covered in the Healthcare Nanomedicine Market report?

Ans: The Types covered in the Healthcare Nanomedicine Market report are Nanoparticle Drug, Nanocarrier Drug

Recommended Reports

Healthcare Nanotech

Precision & Genomic Medicine

Healthcare IT Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Healthcare Nanomedicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nanoparticle Drug

1.2.3 Nanocarrier Drug

1.3 Market by Application

1.3.1 Global Healthcare Nanomedicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Anticancer

1.3.3 CNS Product

1.3.4 Anti-infective

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Healthcare Nanomedicine Market Perspective (2020-2031)

2.2 Global Healthcare Nanomedicine Growth Trends by Region

2.2.1 Global Healthcare Nanomedicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Healthcare Nanomedicine Historic Market Size by Region (2020-2025)

2.2.3 Healthcare Nanomedicine Forecasted Market Size by Region (2026-2031)

2.3 Healthcare Nanomedicine Market Dynamics

2.3.1 Healthcare Nanomedicine Industry Trends

2.3.2 Healthcare Nanomedicine Market Drivers

2.3.3 Healthcare Nanomedicine Market Challenges

2.3.4 Healthcare Nanomedicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Healthcare Nanomedicine Players by Revenue

3.1.1 Global Top Healthcare Nanomedicine Players by Revenue (2020-2025)

3.1.2 Global Healthcare Nanomedicine Revenue Market Share by Players (2020-2025)

3.2 Global Healthcare Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Healthcare Nanomedicine Revenue

3.4 Global Healthcare Nanomedicine Market Concentration Ratio

3.4.1 Global Healthcare Nanomedicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanomedicine Revenue in 2024

3.5 Global Key Players of Healthcare Nanomedicine Head office and Area Served

3.6 Global Key Players of Healthcare Nanomedicine, Product and Application

3.7 Global Key Players of Healthcare Nanomedicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare Nanomedicine Breakdown Data by Type

4.1 Global Healthcare Nanomedicine Historic Market Size by Type (2020-2025)

4.2 Global Healthcare Nanomedicine Forecasted Market Size by Type (2026-2031)

5 Healthcare Nanomedicine Breakdown Data by Application

5.1 Global Healthcare Nanomedicine Historic Market Size by Application (2020-2025)

5.2 Global Healthcare Nanomedicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Healthcare Nanomedicine Market Size (2020-2031)

6.2 North America Healthcare Nanomedicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Healthcare Nanomedicine Market Size by Country (2020-2025)

6.4 North America Healthcare Nanomedicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Healthcare Nanomedicine Market Size (2020-2031)

7.2 Europe Healthcare Nanomedicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Healthcare Nanomedicine Market Size by Country (2020-2025)

7.4 Europe Healthcare Nanomedicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Healthcare Nanomedicine Market Size (2020-2031)

8.2 Asia-Pacific Healthcare Nanomedicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Healthcare Nanomedicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Healthcare Nanomedicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Healthcare Nanomedicine Market Size (2020-2031)

9.2 Latin America Healthcare Nanomedicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Healthcare Nanomedicine Market Size by Country (2020-2025)

9.4 Latin America Healthcare Nanomedicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Healthcare Nanomedicine Market Size (2020-2031)

10.2 Middle East & Africa Healthcare Nanomedicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Healthcare Nanomedicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Healthcare Nanomedicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Healthcare Nanomedicine Introduction

11.1.4 Amgen Revenue in Healthcare Nanomedicine Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Teva Pharmaceuticals

11.2.1 Teva Pharmaceuticals Company Details

11.2.2 Teva Pharmaceuticals Business Overview

11.2.3 Teva Pharmaceuticals Healthcare Nanomedicine Introduction

11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanomedicine Business (2020-2025)

11.2.5 Teva Pharmaceuticals Recent Development

11.3 UCB

11.3.1 UCB Company Details

11.3.2 UCB Business Overview

11.3.3 UCB Healthcare Nanomedicine Introduction

11.3.4 UCB Revenue in Healthcare Nanomedicine Business (2020-2025)

11.3.5 UCB Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Healthcare Nanomedicine Introduction

11.4.4 Roche Revenue in Healthcare Nanomedicine Business (2020-2025)

11.4.5 Roche Recent Development

11.5 Celgene

11.5.1 Celgene Company Details

11.5.2 Celgene Business Overview

11.5.3 Celgene Healthcare Nanomedicine Introduction

11.5.4 Celgene Revenue in Healthcare Nanomedicine Business (2020-2025)

11.5.5 Celgene Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Healthcare Nanomedicine Introduction

11.6.4 Sanofi Revenue in Healthcare Nanomedicine Business (2020-2025)

11.6.5 Sanofi Recent Development

11.7 Merck & Co

11.7.1 Merck & Co Company Details

11.7.2 Merck & Co Business Overview

11.7.3 Merck & Co Healthcare Nanomedicine Introduction

11.7.4 Merck & Co Revenue in Healthcare Nanomedicine Business (2020-2025)

11.7.5 Merck & Co Recent Development

11.8 Biogen

11.8.1 Biogen Company Details

11.8.2 Biogen Business Overview

11.8.3 Biogen Healthcare Nanomedicine Introduction

11.8.4 Biogen Revenue in Healthcare Nanomedicine Business (2020-2025)

11.8.5 Biogen Recent Development

11.9 Gilead Sciences

11.9.1 Gilead Sciences Company Details

11.9.2 Gilead Sciences Business Overview

11.9.3 Gilead Sciences Healthcare Nanomedicine Introduction

11.9.4 Gilead Sciences Revenue in Healthcare Nanomedicine Business (2020-2025)

11.9.5 Gilead Sciences Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Healthcare Nanomedicine Introduction

11.10.4 Pfizer Revenue in Healthcare Nanomedicine Business (2020-2025)

11.10.5 Pfizer Recent Development

11.11 Leadiant Biosciences

11.11.1 Leadiant Biosciences Company Details

11.11.2 Leadiant Biosciences Business Overview

11.11.3 Leadiant Biosciences Healthcare Nanomedicine Introduction

11.11.4 Leadiant Biosciences Revenue in Healthcare Nanomedicine Business (2020-2025)

11.11.5 Leadiant Biosciences Recent Development

11.12 Kyowa Hakko Kirin

11.12.1 Kyowa Hakko Kirin Company Details

11.12.2 Kyowa Hakko Kirin Business Overview

11.12.3 Kyowa Hakko Kirin Healthcare Nanomedicine Introduction

11.12.4 Kyowa Hakko Kirin Revenue in Healthcare Nanomedicine Business (2020-2025)

11.12.5 Kyowa Hakko Kirin Recent Development

11.13 Takeda

11.13.1 Takeda Company Details

11.13.2 Takeda Business Overview

11.13.3 Takeda Healthcare Nanomedicine Introduction

11.13.4 Takeda Revenue in Healthcare Nanomedicine Business (2020-2025)

11.13.5 Takeda Recent Development

11.14 Ipsen

11.14.1 Ipsen Company Details

11.14.2 Ipsen Business Overview

11.14.3 Ipsen Healthcare Nanomedicine Introduction

11.14.4 Ipsen Revenue in Healthcare Nanomedicine Business (2020-2025)

11.14.5 Ipsen Recent Development

11.15 Endo International

11.15.1 Endo International Company Details

11.15.2 Endo International Business Overview

11.15.3 Endo International Healthcare Nanomedicine Introduction

11.15.4 Endo International Revenue in Healthcare Nanomedicine Business (2020-2025)

11.15.5 Endo International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Teva Pharmaceuticals

UCB

Roche

Celgene

Sanofi

Merck

Biogen

Gilead Sciences

Pfizer Inc

Leadiant Biosciences

Kyowa Hakko Kirin

Takeda

Ipsen S A

Endo International

List of Tables

Table 1. Global Healthcare Nanomedicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nanoparticle Drug

Table 3. Key Players of Nanocarrier Drug

Table 4. Global Healthcare Nanomedicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Healthcare Nanomedicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Healthcare Nanomedicine Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Healthcare Nanomedicine Market Share by Region (2020-2025)

Table 8. Global Healthcare Nanomedicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Healthcare Nanomedicine Market Share by Region (2026-2031)

Table 10. Healthcare Nanomedicine Market Trends

Table 11. Healthcare Nanomedicine Market Drivers

Table 12. Healthcare Nanomedicine Market Challenges

Table 13. Healthcare Nanomedicine Market Restraints

Table 14. Global Healthcare Nanomedicine Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Healthcare Nanomedicine Market Share by Players (2020-2025)

Table 16. Global Top Healthcare Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanomedicine as of 2024)

Table 17. Ranking of Global Top Healthcare Nanomedicine Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Healthcare Nanomedicine Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Healthcare Nanomedicine, Headquarters and Area Served

Table 20. Global Key Players of Healthcare Nanomedicine, Product and Application

Table 21. Global Key Players of Healthcare Nanomedicine, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Healthcare Nanomedicine Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Healthcare Nanomedicine Revenue Market Share by Type (2020-2025)

Table 25. Global Healthcare Nanomedicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Healthcare Nanomedicine Revenue Market Share by Type (2026-2031)

Table 27. Global Healthcare Nanomedicine Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Healthcare Nanomedicine Revenue Market Share by Application (2020-2025)

Table 29. Global Healthcare Nanomedicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Healthcare Nanomedicine Revenue Market Share by Application (2026-2031)

Table 31. North America Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Healthcare Nanomedicine Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Healthcare Nanomedicine Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Healthcare Nanomedicine Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Healthcare Nanomedicine Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Healthcare Nanomedicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Healthcare Nanomedicine Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Healthcare Nanomedicine Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Healthcare Nanomedicine Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Healthcare Nanomedicine Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Healthcare Nanomedicine Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Healthcare Nanomedicine Market Size by Country (2026-2031) & (US$ Million)

Table 46. Amgen Company Details

Table 47. Amgen Business Overview

Table 48. Amgen Healthcare Nanomedicine Product

Table 49. Amgen Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 50. Amgen Recent Development

Table 51. Teva Pharmaceuticals Company Details

Table 52. Teva Pharmaceuticals Business Overview

Table 53. Teva Pharmaceuticals Healthcare Nanomedicine Product

Table 54. Teva Pharmaceuticals Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 55. Teva Pharmaceuticals Recent Development

Table 56. UCB Company Details

Table 57. UCB Business Overview

Table 58. UCB Healthcare Nanomedicine Product

Table 59. UCB Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 60. UCB Recent Development

Table 61. Roche Company Details

Table 62. Roche Business Overview

Table 63. Roche Healthcare Nanomedicine Product

Table 64. Roche Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 65. Roche Recent Development

Table 66. Celgene Company Details

Table 67. Celgene Business Overview

Table 68. Celgene Healthcare Nanomedicine Product

Table 69. Celgene Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 70. Celgene Recent Development

Table 71. Sanofi Company Details

Table 72. Sanofi Business Overview

Table 73. Sanofi Healthcare Nanomedicine Product

Table 74. Sanofi Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Merck & Co Company Details

Table 77. Merck & Co Business Overview

Table 78. Merck & Co Healthcare Nanomedicine Product

Table 79. Merck & Co Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 80. Merck & Co Recent Development

Table 81. Biogen Company Details

Table 82. Biogen Business Overview

Table 83. Biogen Healthcare Nanomedicine Product

Table 84. Biogen Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 85. Biogen Recent Development

Table 86. Gilead Sciences Company Details

Table 87. Gilead Sciences Business Overview

Table 88. Gilead Sciences Healthcare Nanomedicine Product

Table 89. Gilead Sciences Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 90. Gilead Sciences Recent Development

Table 91. Pfizer Company Details

Table 92. Pfizer Business Overview

Table 93. Pfizer Healthcare Nanomedicine Product

Table 94. Pfizer Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 95. Pfizer Recent Development

Table 96. Leadiant Biosciences Company Details

Table 97. Leadiant Biosciences Business Overview

Table 98. Leadiant Biosciences Healthcare Nanomedicine Product

Table 99. Leadiant Biosciences Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 100. Leadiant Biosciences Recent Development

Table 101. Kyowa Hakko Kirin Company Details

Table 102. Kyowa Hakko Kirin Business Overview

Table 103. Kyowa Hakko Kirin Healthcare Nanomedicine Product

Table 104. Kyowa Hakko Kirin Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 105. Kyowa Hakko Kirin Recent Development

Table 106. Takeda Company Details

Table 107. Takeda Business Overview

Table 108. Takeda Healthcare Nanomedicine Product

Table 109. Takeda Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 110. Takeda Recent Development

Table 111. Ipsen Company Details

Table 112. Ipsen Business Overview

Table 113. Ipsen Healthcare Nanomedicine Product

Table 114. Ipsen Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 115. Ipsen Recent Development

Table 116. Endo International Company Details

Table 117. Endo International Business Overview

Table 118. Endo International Healthcare Nanomedicine Product

Table 119. Endo International Revenue in Healthcare Nanomedicine Business (2020-2025) & (US$ Million)

Table 120. Endo International Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Healthcare Nanomedicine Picture

Figure 2. Global Healthcare Nanomedicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Healthcare Nanomedicine Market Share by Type: 2024 VS 2031

Figure 4. Nanoparticle Drug Features

Figure 5. Nanocarrier Drug Features

Figure 6. Global Healthcare Nanomedicine Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Healthcare Nanomedicine Market Share by Application: 2024 VS 2031

Figure 8. Anticancer Case Studies

Figure 9. CNS Product Case Studies

Figure 10. Anti-infective Case Studies

Figure 11. Other Case Studies

Figure 12. Healthcare Nanomedicine Report Years Considered

Figure 13. Global Healthcare Nanomedicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Healthcare Nanomedicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Healthcare Nanomedicine Market Share by Region: 2024 VS 2031

Figure 16. Global Healthcare Nanomedicine Market Share by Players in 2024

Figure 17. Global Top Healthcare Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanomedicine as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Healthcare Nanomedicine Revenue in 2024

Figure 19. North America Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Healthcare Nanomedicine Market Share by Country (2020-2031)

Figure 21. United States Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Healthcare Nanomedicine Market Share by Country (2020-2031)

Figure 25. Germany Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Healthcare Nanomedicine Market Share by Region (2020-2031)

Figure 33. China Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Healthcare Nanomedicine Market Share by Country (2020-2031)

Figure 41. Mexico Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Healthcare Nanomedicine Market Share by Country (2020-2031)

Figure 45. Turkey Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Healthcare Nanomedicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Amgen Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 50. UCB Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 52. Celgene Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 54. Merck & Co Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 55. Biogen Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 56. Gilead Sciences Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 58. Leadiant Biosciences Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 59. Kyowa Hakko Kirin Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 60. Takeda Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 61. Ipsen Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 62. Endo International Revenue Growth Rate in Healthcare Nanomedicine Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nanotechnology for Healthcare Market Insights Forecast to 2030

Nanotechnology in Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nanomedicine and Nanobiotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Nanotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nano Healthcare Technology for Medical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanotechnology in Medical Market Insights Forecast to 2030

Global Nano Medical Device Market Research Report 2025

Global Nanotechnology Medical Devices Market Research Report 2025

Nanotechnology in Medical Equipment Market

Global Nanorobotics Market Insights Forecast to 2030

Global Nanomedicine Development and Manufacturing Services Market Research Report 2025

Nanotechnology in Dental Implant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nanomaterials in Personalized Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanorobotics in Medicine Market Research Report 2025

Gold Nanoparticles in Biology and Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Healthcare Mobile Application Market Research Report 2024

Cloud Computing Services for the Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare Cloud Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Semiconductor in Healthcare Market Insights Forecast to 2030

RELATED REPORTS

Global Virtual Reality in Healthcare Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8O6272

Sat Sep 20 00:00:00 UTC 2025

Add to Cart

Global Automotive Engineering Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31N977

Sat Sep 20 00:00:00 UTC 2025

Add to Cart

Global Industry 4.0 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23H2166

Sat Sep 20 00:00:00 UTC 2025

Add to Cart

Global Virtual Reality (VR) in Gaming Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29B5980

Sat Sep 20 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions